Wes Bolsen bolsters Codexis' marketing
This article was originally published in Scrip
Codexis, an industrial biotechnology company whose partners include Merck and Pfizer, has appointed Wesley Bolsen vice-president and chief marketing officer, reporting to president and CEO Alan Shaw. Mr Bolsen joins Codexis from Coskata where he served since 2007, most recently as chief marketing officer. Prior to Coskata he served as chief financial officer for ICM.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.